ESMO 2018: Avelumab plus axitinib combination shows great promise as first-line treatment for advanced RCC
Results from the JAVELIN Renal 101 phase 3 study to [...]
Results from the JAVELIN Renal 101 phase 3 study to [...]
A clinical trial looking at the combination of avelumab plus [...]
The immunotherapy drug avelumab (Bavencio) has been designated a breakthrough [...]